The first step in evaluating patients with elevated prolactin levels is to consider the possibility of autonomous prolactin secretion by a functioning pituitary tumor, usually a prolactinoma, which is the most frequent type of pituitary adenoma and the most common cause of pathological endogenous hyperprolactinemia. This evidence concerns the gene PRL and pituitary gland adenoma.